CANTEX PHARMACEUTICALS, INC. - 14 Sep 2021 Form 4 Insider Report for CHIMERIX INC

Role
10%+ Owner
Signature
/s/ Juan F. Rodriguez, Chief Financial Officer
Issuer symbol
N/A
Transactions as of
14 Sep 2021
Net transactions value
-$37,375,000
Form type
4
Filing time
16 Sep 2021, 16:05:19 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock, par value $0.001 Sale $37,375,000 -6,500,000 -65% $5.75* 3,500,000 14 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

CANTEX PHARMACEUTICALS, INC. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.